No conclusions can be drawn about medical cannabis for head and neck cancer due to extremely limited research
A systematic review found only five studies on cannabis and head and neck cancer, none of which provided standardized dosing, making it impossible to draw conclusions about benefits or harms.
Quick Facts
What This Study Found
Only five studies met inclusion criteria, most investigating recreational rather than medical cannabis. Studies varied in quality and none reported standardized cannabis dosing. Meta-analysis was not possible due to variability in reported outcomes.
Key Numbers
Only 5 studies met inclusion criteria; most studied recreational cannabis; only 1 study reported dosing; meta-analysis was not possible
How They Did This
Systematic review of PubMed, Embase, and Web of Science with no time limit, following standard methodology with two independent reviewers for screening and one for data extraction.
Why This Research Matters
Head and neck cancer patients frequently deal with pain, nausea, and difficulty eating, all conditions where cannabis is commonly used. The almost complete absence of evidence is itself a significant finding.
The Bigger Picture
This systematic review finding of almost no evidence highlights a pattern seen across many cancer types: patients are using cannabis for symptom management while clinicians have virtually no data to guide them.
What This Study Doesn't Tell Us
The absence of evidence does not prove absence of effect. The extremely limited literature prevented meaningful analysis. Publication bias may have excluded relevant data.
Questions This Raises
- ?Why has so little research been conducted on cannabis for this common cancer type?
- ?Would CBD-dominant products help with mucositis or other head and neck cancer-specific symptoms?
- ?What study designs would be most feasible for this population?
Trust & Context
- Key Stat:
- Only 5 studies exist on cannabis and head and neck cancer
- Evidence Grade:
- Systematic review limited by an extremely small evidence base with no standardized outcomes
- Study Age:
- Published in 2021. Research on cannabis for specific cancer types remains severely limited.
- Original Title:
- Medical Cannabis as Adjunctive Therapy for Head and Neck Cancer Patients.
- Published In:
- Cureus, 13(9), e18396 (2021)
- Database ID:
- RTHC-03045
Evidence Hierarchy
Analyzes all available research on a topic using a structured method.
What do these levels mean? →Frequently Asked Questions
Can cannabis help with head and neck cancer?
There is essentially no evidence to answer this question. A systematic review found only five relevant studies, none with standardized dosing, making it impossible to draw conclusions.
Why is there so little research?
Cannabis research faces regulatory barriers, and head and neck cancer specifically has received very little attention in cannabinoid studies. The lack of evidence does not mean cannabis is ineffective, only that it has not been properly studied.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-03045APA
Caputo, Mathew P; Rodriguez, Carmen S; Padhya, Tapan A; Mifsud, Matthew J. (2021). Medical Cannabis as Adjunctive Therapy for Head and Neck Cancer Patients.. Cureus, 13(9), e18396. https://doi.org/10.7759/cureus.18396
MLA
Caputo, Mathew P, et al. "Medical Cannabis as Adjunctive Therapy for Head and Neck Cancer Patients.." Cureus, 2021. https://doi.org/10.7759/cureus.18396
RethinkTHC
RethinkTHC Research Database. "Medical Cannabis as Adjunctive Therapy for Head and Neck Can..." RTHC-03045. Retrieved from https://rethinkthc.com/research/caputo-2021-medical-cannabis-as-adjunctive
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.